A Clinico-epidemiological Profile of Dyslipidaemia and its Association with Temperament - A Cross Sectional Study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Introduction: Dyslipidaemia is directly associated with cardiovascular diseases. Temperament, the unique constitutional make-up of an individual, is responsible for one's personality traits, physical appearances, and disease predispositions. The rising prevalence of dyslipidaemia becomes a challenge to control morbidity and mortality due to cardiovascular diseases. Objective: To study clinical patterns and risk factors of dyslipidaemia and its association with temperament at the individual level was the main objective of this study. Materials and Methods: It was a descriptive and analytical cross sectional study. The participants (n=88) were screened on the basis of raised serum lipid profile from the outpatient department of National Research Institute of Unani Medicine for Skin Disorders, Hyderabad. The data were collected on a case record form designed for this study and analyzed retrospectively. Results: In this study, there were 57% participants (n=50) of phlegmatic temperament in which mean total cholesterol, triglycerides, low density lipoprotein- cholesterol and high density lipoprotein-cholesterol were 230.92 (±49.48) mg/dl, 182.34 (±110.61) mg/dl, 153.24 (±50.21) mg/dl and 46.3 (±10.83) mg/dl respectively. Discussion: This study showed the prevalence of different clinical patterns of dyslipidaemia in the population and the phlegmatic participants were dyslipidaemic in a higher percentage. The prevalence of dyslipidaemia in phlegmatic participants may be linked to the constitutional make-up of the individual. The temperament of an individual may be considered as one of the risk factors for dyslipidaemia. Conclusion: It was concluded that the temperament of an individual may be used as a screening tool to predict the individual’s tendency to develop dyslipidaemia.
Abstract
Introduction: Dyslipidaemia is directly associated with cardiovascular diseases. Temperament, the unique constitutional make-up of an individual, is responsible for one's personality traits, physical appearances, and disease predispositions. The rising prevalence of dyslipidaemia becomes a challenge to control morbidity and mortality due to cardiovascular diseases. Objective: To study clinical patterns and risk factors of dyslipidaemia and its association with temperament at the individual level was the main objective of this study. Materials and Methods: It was a descriptive and analytical cross sectional study. The participants (n=88) were screened on the basis of raised serum lipid profile from the outpatient department of National Research Institute of Unani Medicine for Skin Disorders, Hyderabad. The data were collected on a case record form designed for this study and analyzed retrospectively. Results: In this study, there were 57% participants (n=50) of phlegmatic temperament in which mean total cholesterol, triglycerides, low density lipoprotein- cholesterol and high density lipoprotein-cholesterol were 230.92 (±49.48) mg/dl, 182.34 (±110.61) mg/dl, 153.24 (±50.21) mg/dl and 46.3 (±10.83) mg/dl respectively. Discussion: This study showed the prevalence of different clinical patterns of dyslipidaemia in the population and the phlegmatic participants were dyslipidaemic in a higher percentage. The prevalence of dyslipidaemia in phlegmatic participants may be linked to the constitutional make-up of the individual. The temperament of an individual may be considered as one of the risk factors for dyslipidaemia. Conclusion: It was concluded that the temperament of an individual may be used as a screening tool to predict the individual’s tendency to develop dyslipidaemia.
참고문헌 (23)
- Abd M, "The Correlation of Dyslipidemia with the Extent of Coronary Artery Disease in the Multiethnic Study of Atherosclerosis", Journal of Lipid Research, pp.1~9 (2018)
- Ahirwar R, "Prevalence of obesity in India: A systematic review", Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 13, pp.318~321 (2019)[DOI]
- Sazid Alam, "A Randomized single blind controlled clinical trial on safety and efficacy of a Unani formulation (Itrifal-e-Sagheer) in dyslipidemia", 셀메드, 10(1), pp.8~8 (2020), 셀메드 세포교정의약학회[DOI]
- Anonymous, "Unani Medicine in India-An overview", pp.25~ (2016), Central Council for Research in Unani Medicine
- Bays HE, "Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association", Journal of Clinical Lipidology, 7, pp.304~383 (2013)[DOI]
- Berawi KN, "Dyslipidemia Incidents Between General Obesity and Central Obesity of Employees with Obesity at Universitas Lampung", Biomedical and Pharmacology Journal, 11(1), pp.201~207 (2018)[DOI]
- Carr MC, "Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk", Journal of Clinical Endocrinology and Metabolism, 89(6), pp.2601~2607 (2004)[DOI]
- Chang YC, "Dyslipidemia and diabetic retinopathy", Review of Diabetic Studies, 10(2–3), pp.121~132 (2013)[DOI]
- Fodor G, "Primary Prevention of CVD : Treating Dyslipidemia", American Family Physician, 83(10), pp.1207~1208 (2011)
- Ravinder Garg, "Association of atherosclerosis with dyslipidemia and co-morbid conditions: A descriptive study", Journal of Natural Science, Biology and Medicine, 6(1), pp.163~ (2015), Medknow[DOI]
- Hirano T., "Pathophysiology of Diabetic Dyslipidemia", Journal of Atherosclerosis and Thrombosis, 25, pp.771~782 (2018)
- Hoosen M., "Temperament-an important principle for health preservation in Tibb an-Nabawi and Unani-Tibb", Bangladesh Journal of Medical Science, 16(4), pp.487~495 (2017)
- Karthikeyan G, "Lipid Profile, Plasma Apolipoproteins, and Risk of a First Myocardial Infarction Among Asians", Journal of the American College of Cardiology, 53(3), pp.244~253 (2009)[DOI]
- Kawanami D, "Dyslipidemia in diabetic nephropathy", Renal Replacement Therapy, 2(16), pp.1~9 (2016)[DOI]
- Mahalle N, "Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease", Indian Journal of Endocrinology and Metabolism, 18(1), pp.48~55 (2014)[DOI]
- Munjal YP, "API Textbook of Medicine" (2012), The Association of Physicians of India
- Otsuka T, "Dyslipidemia and the Risk of Developing Hypertension in a Working-Age Male Population", Journal of the American Heart Association, 5(3), pp.1~9 (2016)[DOI]
- Paccaud F, "yslipidemia and abdominal obesity: an assessment in three general populations", Journal of Clinical Epidemiology, 53(4), pp.393~400 (2000)[DOI]
- Pretis Nde, "Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management", United European Gastroenterology Journal, 6(5), pp.649~655 (2018)[DOI]
- Saeed AA, "Anthropometric predictors of dyslipidemia among adults in Saudi Arabia", Epidemiology Biostatistics and Public Health, 10(1), pp.1~11 (2013)[DOI]
- Sarkar P, "Utility of Anthropometric Indices as a Predictor of Dyslipidemia", Journal of Medical Sciences and Health, 01(03), pp.10~13 (2015)[DOI]
- "The Global Health Observatory" (2011)[URL]
- "Global Health Observatory (GHO) data" (2016)[URL]